News | December 15, 2022
Briefs: Jubilant Pharmova and Apollo Hospitals Enterprise
The company will submit an action plan on the observations and will engage with US FDA for next steps.
The company will submit an action plan on the observations and will engage with US FDA for next steps.
In fact, the overall CPHI Pharma Index – a collateralised metric of all major ranking categories – has risen by more than 8%, the largest year-on-year gain in the survey’s six year history
The new production line is equipped with the latest advanced manufacturing system to produce quality products of Alkaloids & APIs used in a wide range of pharmaceutical applications
The pre-approval inspection of USFDA was completed successfully with ZERO 483 observation of the manufacturing facilities of Bajaj Healthcare Limited
Once the unit is made fully functional, it will help the company in increasing its API and intermediate production capacity
For the last ten financial years, the company has posted healthy performance with its revenue from operations growing at 15% CAGR and net profit at 23% CAGR
Sud has more than 32 years of work experience with different companies like Clivient, Jubilant Life Sciences, Piramal Enterprises, Parabolic Drugs, Orchid Chemicals and Pharmaceuticals, Ranbaxy Labs, and Lupin
The company plans to execute both these tenders at their API manufacturing unit located at Savli, Gujarat, India.
The expansion positions Cambrex with the largest and most advanced API facility in the United States
Technology adoption helped the industry to sail through Covid-19 disruption as it understood the need to digitize, learn, and excel
Subscribe To Our Newsletter & Stay Updated
